First Light Acquisition Group, Inc. announced private placement of 2 non-convertible, zero coupon, unsecured promissory notes issued to Metric Finance Holdings III, LLC, and First Light Acquisition Group, LLC for gross proceeds of $490,000 on September 13, 2022. Note with principal amount $366,233 was issued to First Light Acquisition Group, LLC and note with principal amount $123,767 was issued to Metric Finance Holdings III, LLC. The notes will mature upon the company's business combination transaction.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1579 USD | -5.45% | -23.76% | -89.54% |
Apr. 16 | Calidi Biotherapeutics Prices $6.1 Million Offering | MT |
Mar. 21 | H.C. Wainwright Lowers Price Target on Calidi Biotherapeutics to $2 From $11, Maintains Buy Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-89.54% | 8.47M | |
-1.51% | 105B | |
+3.22% | 97.5B | |
+1.86% | 22.19B | |
-16.53% | 21.33B | |
-8.49% | 18.68B | |
-42.33% | 16.6B | |
-20.09% | 14.52B | |
+5.47% | 14.09B | |
+28.85% | 10.99B |
- Stock Market
- Equities
- CLDI Stock
- News Calidi Biotherapeutics, Inc.
- First Light Acquisition Group, Inc. announced that it has received $0.49 million in funding